China, Nov. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A 24-week real-world study of Upadacitinib in the treatment of patients with moderate to severe hidradenitis suppurative'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136808
Registration Time: 2026/11/16
Type: Observational study
Primary Sponsor: Peking Union Medical College Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=352729
Published by HT Digital Content Services with permission from Health Daily Digest....